Previous 10 | Next 10 |
Kill Cliff FC is One of the world’s largest MMA Training Centers with More T han 80 P rofessional F ighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading re...
BioStem Technologies press release ( OTCPK:BSEM ): Q3 GAAP EPS of -$0.14. Revenue of $1.15M misses by $1.05M . For further details see: BioStem Technologies GAAP EPS of -$0.14, revenue of $1.15M misses by $1.05M
Company to Host a Conference Call and Webcast on November 15 , 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commerci...
POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced it will host a conference call to discuss ...
Medicine company BioStem Technologies ( OTCPK:BSEM ) promoted Michael Fortunato to the position of CFO from the role of controller, effective immediately. Fortunato has over 28 years of expert level financial accounting, SEC reporting, M&A and IPO experience. ...
POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allograf...
POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allografts, today announced that Jason Matuszewski, Chief...
Standardi zed methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje ® and Vendaje AC ® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE NEWSWIR...
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allografts, today announced the appointment of Brandon Poe as...
BioStem Technologies press release ( OTCPK:BSEM ): Q2 GAAP EPS of -$0.02. Revenue of $2.16M (+132.3% Y/Y). For further details see: BioStem Technologies GAAP EPS of -$0.02, revenue of $2.16M
News, Short Squeeze, Breakout and More Instantly...
BioStem Technologies Inc Company Name:
BSEM Stock Symbol:
OTCMKTS Market:
BioStem Technologies Inc Website:
Miami, Florida--(Newsfile Corp. - July 16, 2024) - Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be life savers to millions needing better and more effective healthcare solutions. While that need ...
POMPANO BEACH, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved a clinic...
POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that an article validating ...